Frank Rimerman Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Frank Rimerman Advisors's NVS Position: Q1 2026 in Review
Frank Rimerman Advisors increased its Novartis (NVS) stake by 1.6% in Q1 2026, buying an estimated $27K and bringing the position to 11,444 shares worth $1.75M. The position accounts for 0.11% of the portfolio, ranked #143.
Frank Rimerman Advisors first reported a position in NVS in Q2 2024 and has held it in 7 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Frank Rimerman Advisors held 11,444 shares of Novartis worth $1.75M as of Q1 2026.
- Frank Rimerman Advisors bought 176 Novartis shares in Q1 2026, an estimated $27K.
- Novartis made up 0.11% of Frank Rimerman Advisors's portfolio in Q1 2026, its #143 holding.
- Frank Rimerman Advisors first reported a position in Novartis in Q2 2024 and has held it in 7 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.